Joshua R Cook, MD, PhD
Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joshua R Cook, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:12 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07778524 · Alpelisib Challenge Test (ACT)Columbia University · recruiting · Insulin Resistance, Type 2 Diabetes, Obesity & Overweight · principal investigator
- Ph1NCT07403604 · Effect of Insulin Lowering on LipogenesisColumbia University · recruiting · Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease · principal investigator
- Ph1NCT06606327 · Diazoxide Suppression Test P&F StudyColumbia University · terminated · Insulin Resistance, Hyperinsulinemia, Obesity · principal investigator
- Ph1NCT06592261 · Graded Insulin Suppression Test P&FColumbia University · completed · Insulin Resistance, Hyperinsulinemia, Obesity · principal investigator
- Ph1NCT06558422 · Human Models of Selective Insulin Resistance: Pancreatic ClampColumbia University · not yet recruiting · Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease · principal investigator
- Ph1NCT06354088 · Human Models of Selective Insulin Resistance: Alpelisib, Part IColumbia University · recruiting · Insulin Resistance, Prediabetic State, Overweight and Obesity · principal investigator
- N/ANCT06242847 · Role of Insulin Action in Psoriasis PathogenesisColumbia University · terminated · Psoriasis, Plaque Psoriasis, Insulin Resistance · principal investigator
- Ph1NCT06126354 · Dexamethasone/Pancreatic Clamp P&FColumbia University · withdrawn · Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease · principal investigator
- Ph1NCT05733455 · Effect of Alpelisib in Healthy VolunteersColumbia University · completed · Insulin Resistance, Hyperinsulinemia, Dyslipidemias · principal investigator
- Ph1NCT05729282 · Glycemic Effect of Diazoxide in NAFLDColumbia University · completed · Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease · principal investigator
- Ph1NCT05724134 · Pancreatic Clamp in NAFLDColumbia University · completed · Insulin Resistance, Prediabetic State, Hyperinsulinemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Human Models of Selective Insulin ResistanceK23DK140614 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Joshua Robert Cook · fiscal years 2025 to 2026
- Columbia Diabetes Research CenterP30DK063608 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Rebecca Anne Haeusler, Utpal Pajvani · fiscal years 2003 to 2026
- Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)K12DK133995 · NIDDK · STANFORD UNIVERSITY · PI LINDA A DIMEGLIO, David Matthew Maahs · fiscal years 2022 to 2026
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.